Janux Therapeutics, Inc.·4

Sep 22, 6:00 PM ET

Kung Winston 4

4 · Janux Therapeutics, Inc. · Filed Sep 22, 2022

Insider Transaction Report

Form 4
Period: 2022-09-21
Kung Winston
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-09-21+30,00030,000 total
    Exercise: $13.54Exp: 2032-09-20Common Stock (30,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-09-21+9,3759,375 total
    Exercise: $13.54Exp: 2032-09-20Common Stock (9,375 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in equal monthly installments over a three year period following September 21, 2022 (the "Grant Date") such that the option is fully vested on the third anniversary of the Grant Date.
  • [F2]The shares subject to the option vest in equal monthly installments over a one year period following September 21, 2022 (the "Grant Date") such that the option is fully vested on the first anniversary of the Grant Date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION